Cancer patient Beth Wallace speaks about her support system and the impact they have made on her life.
Oncology
Advertisement
The pharma giant will now focus on its PD-1 cancer immunotherapy Keytruda.
Advertisement
Top news of the day from across the health care landscape.
Top news of the day from across the healthcare landscape.
Beth Wallace discusses various treatments for leiomyosarcoma, including doxorubicin (Adriamycin), nicknamed the red devil.
Gadolinium-containing imaging agent could improve breast cancer survival.
Advertisement
Recent studies suggested that hepatitis C antiviral drugs may increase the risk of hepatocellular carcinoma.
In part 2, Beth Wallace describes the events leading up to her diagnosis with leiomyosarcoma.
Pertuzumab-based regimen shows promise treating adjuvant treatment of HER2-positive early breast cancer.
Genentech is seeking approval for Perjeta used in combination with trastuzumab and chemotherapy for adjuvant treatment of HER2-positive early breast cancer.
Advertisement
Consolidative radiation followed by chemotherapy could play a key role in future survival outcomes among patients with non-small cell lung cancer.
New findings suggest alterations in this process may trigger cancer progression.
Top news of the week from Specialty Pharmacy Times.
Top news of the day from across the health care landscape.
Abemaciclib treats adults with hormone receptor-positive, human epidemical growth factor receptor-negative advanced or metastatic breast cancer that progressed after endocrine therapy.
Verzenio can be administered as a stand-alone treatment to patients previously treated with endocrine therapy and chemotherapy.
Officials with the FDA have approved abemaciclib (Verzenio, Eli Lilly), for the treatment of adults with certain advanced or metastatic breast cancer.
Top news of the week from Specialty Pharmacy Times.
Introducing microbes to replace missing metabolites could reduce cancer risk, study suggests.
Women with the hepatitis C virus have fewer live births and face a higher risk of miscarriage, infertility, gestational diabetes and pre-eclampsia.
Many researchers are interested in looking at FDA-approved drugs that could potentially be repositioned for use in cancer treatment.
Physical activity and a whole grain-rich diet lowers colorectal cancer risk, whereas red meat increases the risk.
Exposure to carbon may not increase the risk of death among hardmetal workers.
Patients with peripheral neuropathy may experience pain, numbness, and tingling in the hands and feet, despite cessation of chemotherapy.
Limited proportion of patients with chronic hepatitis C virus received antiviral treatment before the widespread use of direct-acting antivirals.
A newly-discovered molecule can induce programmed cell death in mesenchymal-like lung cancer cells.
Certain adjuvant chemotherapy regimens may lead to long-lasting peripheral neuropathy in breast cancer survivors.
Adjuvant endocrine therapy can prevent cancer recurrence but can result in painful side effects.
Top news of the week from Specialty Pharmacy Times.
Wnt signaling activation impacts the response to melanoma treatment.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Operationalizing Epcoritamab-GemOx in Practice: A Focus on EPCORE NHL-2
2
Under Pressure: A Brief Overview of the Updated Hypertension Guidelines
3
Biosimilar Stivant Shows Noninferior Efficacy and Comparable Safety to Reference Bevacizumab
4
Current and Emerging BCMAxCD3 Bispecifics
5
